Trestolone Acetate (MENT) Powder CAS 6157-87-5
Product name: Trestolone Acetate
Synonyms:17β-Hydroxy-7α-methylestr-4-en-3-one acetate;3-Oxo-7α-methylestra-4-ene-17β-ol acetate;Acetic acid 3-oxo-7α-methylestra-4-ene-17β-yl ester;NSC-69948;U-15614
CAS: 6157-87-5
MF: C21H30O3
MW: 330.465
Appearance: White powder
Purity: 97.8%
Usage: Pharmaceutical raw materials, bodybuilding and sex enhancement.
Trestolone Acetate (MENT) Description:
Chemically speaking, trestolone acetate(MENT) actually an alright looking drug. It doesn’t show much interaction with Sex Hormone Binding Globulin, which means that a good portion ought to stay unbound and active in the blood. Also, the drug is a potent binder to the androgen receptor, while showing minimal affinity for the progesterone and mineralocorticoid receptors respectively.
Since it is not able to be 5a-reduced into a dihydro-version, it likely wouldn’t cause many of the side effects commonly associated with Dihydrotestosterone. This is also a likely reason that it is less apt to cause prostate enlargement, and may even be indicated for the treatment of specific prostate issues.
The ability of 7 alpha-methyl-19-nortestosterone acetate (MENT) to increase the weights of ventral prostate and seminal vesicles of castrated rats was four times higher than that of testosterone, while its effect on the weights of bulbocavernosus plus levator ani muscles (muscle), was 10 times that of testosterone.
Various forms of MENT in human pharmaceutical preparations and devices for contraception and hormone therapy, specifically MENT Ac implant and MENT transdermal gel and patch formulations, are currently under clinical investigation. MENT is absorbed transdermally up to three times the rate of testosterone – 17 methyl testosterone and 17-α methyl testosterone.
MENT will have application in a wide range of indications beyond androgen replacement therapy and contraception, including, without limitation, primary hypogonadism, testicular failure, ASIH, baldness, sarcopenia, loss of bone mass, muscle wasting and cachexia, BPH, prostate cancer and of course, bodybuilding and sports performance enhancement. Trestolone acetate is the chemical name of active ingredient in MENT. MENT is a registered trademark of Population Council, Inc. in the United States and/or other countries.
Trestolone Acetate (MENT) Application:
Trestolone acetate being a transdermal and/or intramuscular preparation, can have application in a wide array of indications beyond androgen replacement therapy and contraception, including, without limitation, primary hypogonadism, testicular failure, ASIH, baldness, sarcopenia, lack of bone mass, muscle wasting and cachexia, BPH, prostate cancer and of course, bodybuilding and sports performance enhancement.
Trestolone can be a synthetic androgen delivered to get buff rapidly, and is a theoretical candidate drug to be used in hormonal male contraceptive methods. Of males, regular administration of sufficient degrees of trestolone induces circumstances of temporaryinfertility. inadequate testosterone levels cause undesirable effects, for example fatigue, loss of skeletal muscles, reduced libido, and fat gain. However, the androgenic and anabolic properties of trestolone largely ameliorate this challenge. Essentially, trestolone replaces testosterone’s role since the primary male hormone within the body.
Light beer 7 alpha-methyl-19-nortestosterone acetate (MENT) to increase the weights of ventral prostate and seminal vesicles of castrated rats was four times above that relating to testosterone, while its influence on the weights of bulbocavernosus plus levator ani muscles (muscle), was 10 times that relating to testosterone. Both Nandrolone and Trenbolone are cousins to MENT, and they are invaluable on either cutting or bulking cycles.
Trestolone Acetate (MENT) Test Report (COA):
| Product name |
Trestolone Acetate |
| Appearance |
White crystalline powder |
| Chromatographic purity |
Any individual impurity not more than 1.0%
Total impurities not more than 2.0% |
0.27%
0.7% |
| Loss on drying |
Not more than 0.5% |
0.1% |
| Residue on ignition |
Not more than 0.2% |
0.1% |
| Residual solvents |
Methanol≤3000ppm
Methylene Chloride≤600ppm
Chloroform≤60ppm
Tetrahydrofuran≤720ppm |
350ppm
Not detect out
Not detect out
Not detect out |
| Assay |
Between 97.0% and 102.0% |
99.25% |
| Micronixation |
90% not more than 10 microns |
90% not more than 10 aicrons |
Rowe Chen
Sales01
Sales Manager